Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-30

Clinical Trial Update: Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating efficacy of serotonergic antidepressants in bulimia nervosa guided by brain serotonin profile via PET imaging with [18F] MPPF.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Bulimia Nervosa | Phase 4 | Status: COMPLETED